Page last updated: 2024-11-04

sulfadiazine and Pancytopenia

sulfadiazine has been researched along with Pancytopenia in 1 studies

Sulfadiazine: One of the short-acting SULFONAMIDES used in combination with PYRIMETHAMINE to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections.
sulfadiazine : A sulfonamide consisting of pyrimidine with a 4-aminobenzenesulfonamido group at the 2-position.
diazine : The parent structure of the diazines.

Pancytopenia: Deficiency of all three cell elements of the blood, erythrocytes, leukocytes and platelets.

Research Excerpts

ExcerptRelevanceReference
"The treatment of reference of congenital toxoplasmosis combines two folate synthesis inhibitors, pyrimethamine and an antibacterial sulfamide (sulfadiazine or sulfadoxine)."1.32[Maternal pancytopenia during antenatal treatment of congenital toxoplasmosis]. ( Coutty, N; Decocq, J; Delahousse, G; Detourmignies, L; Le Goueff, F; Mubiayi, N, 2004)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mubiayi, N1
Coutty, N1
Detourmignies, L1
Le Goueff, F1
Decocq, J1
Delahousse, G1

Other Studies

1 other study available for sulfadiazine and Pancytopenia

ArticleYear
[Maternal pancytopenia during antenatal treatment of congenital toxoplasmosis].
    Presse medicale (Paris, France : 1983), 2004, Aug-28, Volume: 33, Issue:14 Pt 1

    Topics: Adult; Antiprotozoal Agents; Drug Therapy, Combination; Female; Humans; Pancytopenia; Parity; Pregna

2004